Mouse Anti-CST5 Recombinant Antibody (CBYY-C2231) (CBMAB-C3669-YY)

Mohammed, N. U. G., Khaleel, F. M., & Gorial, F. I. (2021). Cystatin D as a new diagnostic marker in rheumatoid arthritis. Gene Reports, 23, 101027.

Fujita-Yoshigaki, J., Yokoyama, M., & Katsumata-Kato, O. (2020). Switching of cargo sorting from the constitutive to regulated secretory pathway by the addition of cystatin D sequence in salivary acinar cells. American Journal of Physiology-Gastrointestinal and Liver Physiology, 319(1), G74-G86.

Wang, F., Zhang, C., Ge, W., & Zhang, G. (2019). Up‐regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF‐κB pathway. Journal of Cellular and Molecular Medicine, 23(10), 6744-6754.

Hill, L. J., Di Pietro, V., Hazeldine, J., Davies, D., Toman, E., Logan, A., & Belli, A. (2018). Author Correction: Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury. Scientific Reports, 8(1), 1-1.

Hill, L. J., Di Pietro, V., Hazeldine, J., Davies, D., Toman, E., Logan, A., & Belli, A. (2017). Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury. Scientific Reports, 7(1), 1-10.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols